Panagiotou, M. O., Elmanfalouty, R., Moyo, C., Papatheodoridi, A., Mekhail, Y. N., Khan, S., Vlachostergios, P. J., Mullamitha, S., Hasan, J., Marti, K., Braun, M., Angelakas, A., Broadbent, R., Saunders, M. P., Kamposioras, K. V. (2026). Stratifying survival benefit of encorafenib/cetuximab (EC) in BRAF V600E–mutant mCRC using clinical and inflammatory biomarkers: Real-world experience from greater Manchester.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15563